MediQStar

MediQStar operates an AI CRO (Contract Research Organization) model called ADC—Accurate Diagnosis and CRO—that combines generative AI technology with clinical trial services to build new processes for complex clinical research. Through AI-driven biosimulation, the company significantly shortens trial timelines and reduces costs. Its research team combines specialists from Seoul National University Hospital and FDA-affiliated overseas experts, and it partners with Vietnam's National Lung Hospital on tuberculosis and dementia data, guided by core values of patient-centricity, reliability, innovation, and ethics.